Instituto De Microcirugia Ocular Dos S.L.
- Address
- Calle De Josep Maria Llado 3, 08017 Barcelona, Spain
Retina and Eye Diseases
At Instituto De Microcirugia Ocular Dos S.L. in Barcelona, clinical research is centered on retinal and ocular diseases, with a strong focus on conditions that affect vision and eye health. The studies are designed to assess new treatments, compare them with established care, and better understand how to preserve or improve sight in people with chronic eye disorders.
- Research in diabetic macular edema and diabetic retinopathy is evaluating whether new eye therapies can improve visual outcomes and reduce disease activity.
- Trials in neovascular age-related macular degeneration are testing innovative approaches, including gene therapy and combination treatment strategies, to support vision preservation.
- Studies in geographic atrophy secondary to age-related macular degeneration are examining new ways to slow lesion growth and assess long-term safety.
- The site is also involved in research on thyroid eye disease, myopia, neurotrophic keratopathy, and persistent corneal epithelial defect, with the aim of improving symptom control and healing.
Overall, the Retina department is contributing to a broad range of ophthalmology studies that combine treatment testing, safety evaluation, and efforts to improve diagnosis and disease management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Eyebiotech Limited1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Eyebiotech Limited3trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Instituto De Microcirugia Ocular Dos S.L.
lock Showing 1 of 15 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Cenegermin Ophthalmic Solution for the Treatment of Persistent Corneal Epithelial Defect: Phase 3 Randomized, Double-Masked, Vehicle-Controlled Study | Dompe' Farmaceutici S.p.A. | Phase III | Recruiting | Jun 2026 | — |
IMP list
lock Showing 1 of 17 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ranibizumab | 4 | Unknown | 2021-09-23 | 2025-10-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.